Replies to post #406151 on Amarin Corp Plc (AMRN)

[ORBAPU]

Thanks. Good article.

[couldbebetter]

Number sleven, Yes, Interesting indeed! (On many levels.)
The sponsor of the study is the largest private pharmaceutical company in the world.
(Based in Germany.) Could they be a prospect to acquire AMRN? Could they help
to get reimbursement for Vazkepa in Germany? (Well, maybe if the owned it.)
Will AMRN management use this article to strengthen their argument with German
Health authorities? (I hope so, that is if the are even aware of this article.)
Have you sent it over to AMRN, and if so, any response?)

This article certainly captures the medical justification for Vazkepa.

[swg_tdr]

# sleven, excellent find. Denner go China!

The cost associated with this disease is devastating. Compounding the costs of diabetes and heart disease paints a bleaker picture; in China from 2006-2015, a $558 billion loss in national income was attributable to heart disease, stroke, and diabetes.